Studies on retinoblastoma have led to several landmark studies in cancer genetics over the past 4 decades. In 1971, Knudson proposed that retinoblastoma might initiate by biallelic inactivation of a putative tumor suppressor gene (Knudson 1971). This “two-hit hypothesis” was based on the observation that there were two distinct forms of retinoblastoma seen in the clinic. Children with a family history of retinoblastoma often had bilateral multifocal retinoblastoma. In contrast, children with unilateral retinoblastoma rarely had any family history of the disease. Knudson proposed that for retinoblastoma to form, both copies of a putative tumor suppressor gene had to be inactivated. Children with a family history of retinoblastoma inherited a defective copy of this tumor suppressor gene and were likely to have retinal cells that sustained mutations in the second allele, leading to multifocal bilateral retinoblastoma. In contrast, children who have two intact copies of the retinoblastoma susceptibility gene develop retinoblastoma only when a single cell sustains two independent mutations that inactivate both copies of the gene. The lower probability of two inactivating mutations in the retinoblastoma susceptibility gene could account for the observation that these children often had unilateral retinoblastoma with fewer tumor foci.
Several years later, Weinberg’s lab cloned Knudson’s putative tumor suppressor gene by studying genetic lesions and chromosomal aberrations in families with a history of retinoblastoma (Friend et al. 1986). This was the first human tumor suppressor gene to be cloned and it was named RB1 (Friend et al. 1986). Initially, researchers believed that RB1 was important for retinoblastoma susceptibility, but its role in other human cancers was unknown until Harbour and colleagues found that the RB1 gene was also mutated in lung cancer (Harbour et al. 1988). Today, it is widely held that most, if not all, tumors have sustained genetic lesions in their Rb pathway that contribute to deregulated cellular proliferation. These landmark studies on the genetics of retinoblastoma susceptibility have had a major impact on our understanding of tumor suppressor genes and have formed the framework for much of our current knowledge of genetic lesions associated with tumorigenesis.
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access
Ajioka I et al (2007) Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131(2):378PubMedCrossRefGoogle Scholar
Aslanian A, Iaquinta PJ, Verona R, Lees JA (2004) Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18(12):1413PubMedCrossRefGoogle Scholar
Chen D et al (2004) Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5(6):539PubMedCrossRefGoogle Scholar
Robanus-Maandag E et al (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12(11):1599PubMedCrossRefGoogle Scholar
Vooijs M, te Riele H, van der Valk M, Berns A (2002) Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21(30):4635Google Scholar